← FDA Drug Approvals (Drugs@FDA)

LITHIUM CARBONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2009-09-25

Drug application

FDA Application #

ANDA090702

Application type

Abbreviated New Drug Application (Generic)

Brand name

LITHIUM CARBONATE

Generic name

LITHIUM CARBONATE

Active ingredients

LITHIUM CARBONATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2009-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown